Speaker
Description
Bashar G. Alfetlawi, Ali L. Jasim
Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Iraq
Abstract
Urinary tract infection (UTI) is one of the most common bacterial diseases. Globally, 150 million people are diagnosed with UTIs annually, which cost more than 6 billion US dollars. UTIs are a spectrum of diseases ranging from simple cystitis to serious infections such as pyelonephritis and other complications in humans. The early treatment of UTIs with empiric antibiotics decreases the rate of morbidity. In order to administer an appropriate empiric therapy, it is critical to know the main bacteria causing UTI as well as their respective antimicrobial susceptibility pattern.
This study is a descriptive quantitative retrospective study. Medical and lab records for 256 adult outpatients who visited Al-Diwaniya tertiary hospitals (Diwaniya Teaching Hospital and Gynecology Teaching Hospital) starting from Jan 2020 till Feb 2022 are reviewed and patients’ sociodemographic (age, gender) and laboratory data (urine sample culture and antibiotic susceptibility test) are collected.
Data analysis revealed that most of the patients were females (204, 79.7%) with a mean age of 39.22±17.10. The prevalent uropathogen was Staphylococcus spp. (100, 39.1%) followed by E. coli (90, 35%) and Klebsiella spp. (23, 9%). Highest antibiotic sensitivity was found with linezolid (46, 100%), vancomycin (69, 90%), meropenem (84, 87%), amikacin (206, 72%) and nitrofurantoin (167, 68%). Highest Bacterial resistance was for ampicillin (82, 94%), ofloxacin (94, 78%), ceftriaxone (114, 76%), ciprofloxacin (208, 62%).
| Has the manuscript been published? | Not published |
|---|---|
| Field/discipline | Clinical/Social Pharmacy |
| Intend to be published in the conference journal (IJPS)? | No |
